It warms our hearts to know we’re making an impact, and as we prepare for another year, we hope to see more people gaining insights and knowledge from our work.It warms our hearts to know we’re making an impact, and as we prepare for another year, we hope to see more people gaining insights and knowledge from our work.

Capping off 2025 with new Gen Z report, big team announcement – The Nerve

2025/12/17 18:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

We have a couple of big announcements at The Nerve, Rappler’s data forensics arm, to cap the year.

This December, we released our latest report aimed at decoding Gen Z and exploring how these digital natives navigate media, work, money, brands, and relationships. For all those looking to understand Gen Zs — or perhaps if you’re a Gen Z looking for insight into your generation’s behavior — we invite you to download the report here.

For this report, we ran online surveys and used Synth, The Nerve’s AI-powered online interview platform, to get key insights straight from Filipino Gen Zs. This study also used Probe, our forensic solutions for narrative and content analysis of online articles and social media posts, to complement the Synth results.

DOWNLOAD THE REPORT HERE

In other news, we’re thrilled to announce that Professor Julie Posetti is joining The Nerve as director of The Information Integrity Initiative (III). The III seeks to anchor action-oriented research, policy work, and product development at the intersection of disinformation, freedom of expression, gender, and public interest media, and Posetti will spearhead efforts to further the cause.

The III’s first major release is called “Tipping Point: The chilling escalation of violence against women in the public sphere.” It showed that 70% of surveyed women have experienced online violence in the course of their work, and that 41% of respondents reported offline harm linked to online abuse.

The report was produced by the EU-UN Women’s ACT to End Violence against Women program in partnership with researchers from The Nerve, City St. George’s University, and the International Center for Journalists, in collaboration with UNESCO. You can download the free report on The Nerve’s website now.

DOWNLOAD THE REPORT HERE

As we end the year, we’d like to thank those of you reading and following The Nerve’s reports or attending our masterclasses. It warms our hearts to know we’re making an impact, and as we prepare for another year, we hope to see more people gaining insights and knowledge from our work.

Here are the other reports we published this year, for those catching up on reading over the holidays:

  • Southport Riot: Inside the UK’s Anti-Immigrant Disinformation Ecosystem
  • [DECODED] Nerve study finds demand for EQ, more personal stories from parenting influencers

See you again next year! – Rappler.com

The Nerve is a data forensics company that enables changemakers to navigate real-world trends and issues through narrative and network investigations. Taking the best of human and machine, we enable partners to unlock powerful insights that shape informed decisions. Composed of a team of data scientists, strategists, award-winning storytellers, and designers, the company is on a mission to deliver data with real-world impact.

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.0004546
$0.0004546$0.0004546
-1.72%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09